Physician

Rabih Nayfe, M.D.

According to 2025 Medicare claims, Rabih Nayfe, M.D. (NPI: 1760823553) practices rheumatology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is STRAND PHYSICIAN SPECIALISTS, PA (NPI: 1194707901; TIN: 570963173) and primary practice location at 29572-4612. Nayfe is affiliated with the Aledade 153 SC MSSP Enhanced (ACO ID: A5356), participating under the MSSP model.

Nayfe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 789 traditional Medicare patients, billed 268,118 HCPCS/CPT codes, and received $2,519,489 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,573 prescription claims across 493 beneficiaries totaling $2,032,910 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 195 records totaling $3,882. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $179,378 to $2,519,489. Similarly, Part D prescription costs have moved sharply higher in recent years, from $9,966 to $2,032,910. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.5M2019 Medicare payment: $179,378 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $932,358 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,372,212 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,523,494 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,276,388 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,519,489 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192189,034$179,378
202055652,670$932,358
2021792150,740$2,372,212
2022782203,337$2,523,494
2023741226,564$2,276,388
2024789268,118$2,519,489

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $9,966 (USD; Tot_Drug_Cst)2016 Drug cost: $17,959 (USD; Tot_Drug_Cst)2017 Drug cost: $27,190 (USD; Tot_Drug_Cst)2019 Drug cost: $35,402 (USD; Tot_Drug_Cst)2020 Drug cost: $436,599 (USD; Tot_Drug_Cst)2021 Drug cost: $793,320 (USD; Tot_Drug_Cst)2022 Drug cost: $874,288 (USD; Tot_Drug_Cst)2023 Drug cost: $1,177,214 (USD; Tot_Drug_Cst)2024 Drug cost: $2,032,910 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201525245$9,966
201620217$17,959
2017N/R19$27,190
2018N/RN/RN/R
201986177$35,402
20202951,362$436,599
20213981,931$793,320
20224281,858$874,288
20234542,183$1,177,214
20244932,573$2,032,910

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less229537$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more382627$87
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's312448$12
36415Insertion of needle into vein for collection of blood sample286495$9
85652Red blood cell sedimentation rate, to detect inflammation, automated248445$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib702,340$499,046
Xeljanz XrTofacitinib Citrate381,560$316,083
Enbrel SureclickEtanercept21784$221,742
Humira(Cf) PenAdalimumab29812$197,743
Orencia ClickjectAbatacept24672$155,577

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.195$3,882ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rabih Nayfe, M.D.?

Tedicare shows public-source Medicare data for Rabih Nayfe, M.D. (NPI 1760823553), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rabih Nayfe, M.D. have ACO affiliation data?

Rabih Nayfe, M.D. is shown with ACO affiliation data for Aledade 153 SC MSSP Enhanced (MSSP, ACO ID A5356).

What billing organization is linked to Rabih Nayfe, M.D.?

Rabih Nayfe, M.D. is linked to STRAND PHYSICIAN SPECIALISTS, PA (billing NPI 1194707901) in the available physician profile data.

Does Rabih Nayfe, M.D. have Open Payments data?

Rabih Nayfe, M.D. has 195 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.